Z79 |
Long term (current) drug therapy |
Z79.0 |
Long term (current) use of anticoagulants and antithrombotics/antiplatelets |
Z79.01 |
Long term (current) use of anticoagulants |
Z79.02 |
Long term (current) use of antithrombotics/antiplatelets |
Z79.1 |
Long term (current) use of non-steroidal anti-inflammatories (NSAID) |
Z79.2 |
Long term (current) use of antibiotics |
Z79.3 |
Long term (current) use of hormonal contraceptives |
Z79.4 |
Long term (current) use of insulin |
Z79.5 |
Long term (current) use of steroids |
Z79.51 |
Long term (current) use of inhaled steroids |
Z79.52 |
Long term (current) use of systemic steroids |
Z79.6 |
Long term (current) use of immunomodulators and immunosuppressants |
Z79.60 |
Long term (current) use of unspecified immunomodulators and immunosuppressants |
Z79.61 |
Long term (current) use of immunomodulator |
Z79.62 |
Long term (current) use of immunosuppressant |
Z79.620 |
Long term (current) use of immunosuppressive biologic |
Z79.621 |
Long term (current) use of calcineurin inhibitor |
Z79.622 |
Long term (current) use of Janus kinase inhibitor |
Z79.623 |
Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor |
Z79.624 |
Long term (current) use of inhibitors of nucleotide synthesis |
Z79.630 |
Long term (current) use of alkylating agent |
Z79.631 |
Long term (current) use of antimetabolite agent |
Z79.632 |
Long term (current) use of antitumor antibiotic |
Z79.633 |
Long term (current) use of mitotic inhibitor |
Z79.634 |
Long term (current) use of topoisomerase inhibitor |
Z79.64 |
Long term (current) use of myelosuppressive agent |
Z79.69 |
Long term (current) use of other immunomodulators and immunosuppressants |
Z79.8 |
Other long term (current) drug therapy |
Z79.81 |
Long term (current) use of agents affecting estrogen receptors and estrogen levels |
Z79.810 |
Long term (current) use of selective estrogen receptor modulators (SERMs) |
Z79.811 |
Long term (current) use of aromatase inhibitors |
Z79.818 |
Long term (current) use of other agents affecting estrogen receptors and estrogen levels |
Z79.82 |
Long term (current) use of aspirin |
Z79.83 |
Long term (current) use of bisphosphonates |
Z79.84 |
Long term (current) use of oral hypoglycemic drugs |
Z79.85 |
Long-term (current) use of injectable non-insulin antidiabetic drugs |
Z79.89 |
Other long term (current) drug therapy |
Z79.890 |
Hormone replacement therapy |
Z79.891 |
Long term (current) use of opiate analgesic |
Z79.899 |
Other long term (current) drug therapy |